Spoštovani kupci!
Zaradi prenove spletne strani in prehoda na OJS spletna prodaja trenutno ne dela. Prosim, če sporočite, kaj bi radi kupili, na prodaja@medrazgl.si. Dopišite vaše ime in priimek, naslov ter način plačila (s predračunom, ob povzetju ali z gotovino, če prezvamete gradivo v živo v prostorih uredištva v času uradnih ur).
Hvala za razumevanje!
MENU
Anatomy
Anesthesiology
Biochemistry
Biomedical Informatics
Biophysics
Cell Biology
Clinical Cases
Dentistry
Dermatovenerology
Emergency Medicine
Family Medicine
Forensic Medicine
Gynecology and Obstetrics
Histology and Embryology
History of Medicine
Human Genetics
Hygiene
Infectious Diseases
Internal Medicine
Medical Deontology and Philosophy
Medical Psychology
Microbiology and Immunology
Neurology
Occupational Medicine
Oncology
Ophthalmology
Orthopaedics
Otorhinolaryngology
Pathology
Pathophysiology
Pediatrics
Pharmacology and Experimental Toxicology
Physical and Rehabilitation Medicine
Physiology
Psychiatry
Radiology
Social Medicine
Surgery
Toxicology
Research papers
Clinical research paper
Preclinical research paper
Sponsored articles
Archive » 2012 » 2 » | Archive » Medical field » Fields » Gynecology and Obstetrics » Archive » Medical field » Fields » Psychiatry »

Premenstrual Syndrome and Premenstrual Dysphoric Disorder

 
Abstract:

This post is also available in: English Slovenščina (Slovenian)

Most women of reproductive age experience some psychological and physical symptoms during the final premenstrual and the initial days of the menstrual cycle. Common complaints include depressed mood, anxiety, irritability, lack of energy, difficulties with concentration, breast tenderness, and bloating. When the symptoms are mild, this is called premenstrual syndrome, while a more severe form of this condition which causes a substantial degree of functional impairment is called premenstrual dysphoric disorder. The paper presents various theories on the etiology and pathophysiology of these entities, along with different treatment options. Current treatments target the serotonergic system or the hypothalamus-pituitary-ovary axis. In Europe, premenstrual syndrome is not treated with drugs. However, doctors in the United States of America, Canada and Australia have reported good results in treating premenstrual disorders with serotonin reuptake inhibitors. Other treatment options are available as well, but evidence of their effectiveness is lacking. With this article, the authors wish to stimulate a debate in Slovene medical circles, so that in the future premenstrual disorders would get the attention they deserve.

Authors:
Janežič Kristina, Dernovšek Mojca Z.

Keywords:
premenstrual syndrome, premenstrual dysphoric disorder, diagnosis, aetiology, treatment

Cite as:
Med Razgl. 2012; 51: 159–75.
© 2024 Društvo Medicinski razgledi | Na vrh strani / To top ↑